Drakenterprises

Not clinical advice. Clinical Evidence is a current-awareness feed. It is not a clinical decision-support system, not medical advice, and not a substitute for clinical judgment, institutional protocols, or the original sources. Full text, NCCN recommendations, and Cochrane review bodies are not reproduced here.

Home · diabetes

DiabetesArticle

Accelerated Brain Aging in Type 1 Diabetes Across Painful and Painless Peripheral Neuropathy: MRI-Based Brain Age Estimates From Deep Learning.

Diabetes · ADA · 08/11/2026

Authors: Hostrup, Søren N F; Croosu, Suganthiya S; Røikjer, Johan; Mørch, Carsten D; Brock, Christina; Drewes, Asbjørn M; Brock, Birgitte; Muthulingam, Janusiya A; Hansen, Tine M; Ejskjaer, Niels; Frøkjær, Jens B

Publication types: Journal Article

PubMed abstract / permitted excerpt

Accelerated brain aging has been reported in diabetes, but its links with diabetic peripheral neuropathy (DPN) and neuropathic pain remain unclear. We explored brain age gap (BAG) in type 1 diabetes to determine if it differs across neuropathic phenotypes, relates to clinical characteristics including DPN measures, and shows distinct regional patterns. Diabetes participants had 3.5 years of BAG, rising to 6-7 years in those with DPN. Diabetes duration was the main driver of BAG, whereas DPN had limited impact and neuropathic pain no clear contribution. BAG was widespread across the brain. Accelerated brain aging appears to affect people with diabetes regardless of neuropathic complications.

Full-text bodies are not stored. Official ADA RSS plus PubMed metadata only.

Clinical Evidence